SEC Form 4 · accession 0001209191-17-050785
Ampio Pharmaceuticals, Inc. · AMPE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Bar-Or
Officer — Chief Scientific Officer · Director
Period of report
Aug 28, 2017
Accepted (ET)
Aug 30, 2017 · 6:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001411906
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $0.50 | Aug 28, 2017 | A | 133,000 | A | Aug 28, 2017 | Aug 27, 2027 | Common Stock | 133,000 | 133,000 | D |
Explanation of responses
- F1The stock option is 100 percent vested and exercisable on the date of grant.